Promotion of biomedical products
Subtitle: regulatory considerations
By: edited by Thomas E. Colonna and Jeffrey K. Shapiro.
Contributors: Colonna, Thomas E.; Shaprio, Jeffrey K.; Food and Drug Law Institute (U.S.)
Publisher: Food and Drug Law Institute
Published: 2006
Place of publication: Washington, D.C
Language: eng
Number of pages: 178
Subjects: Biomedical materials -- Marketing -- Law and legislation -- United States; Drugs -- Law and legislation -- United States; Medical instruments and apparatus industry -- Law and legislation -- United States
Other titles: Biomedical products
Notes: Includes bibliographical references and index.
Table of contents: title: ch. 1.; title: Labeling and advertising of medical devices -- Jeffrey K. Shapiro -- ch. 2.; title: Labeling and advertising of prescription drugs -- Mark D. Learn, Jocelyn D. Rivera and Scott Hatfield -- ch. 3.; title: Labeling and advertising of over-the-counter drugs and medical devices -- Janice M. Hogan, Mark D. Learn, Steven Datlof, and Karen Bates -- ch. 4.; title: Dissemination of "off-label" information: unsolicited requests, journal articles and textbooks, and continuing medical education symposia -- Jeffrey K. Shapiro -- ch. 5.; title: Medicine meets Madison Avenue: the direct-to-consumer advertising of prescription drugs -- William M. Janssen and Gregory J. Wartman -- ch. 6.; title: Labeling of in vitro diagnostic devices -- Randy Prebula -- ch. 7.; title: Promotion of clinical laboratory services -- Debra R. Ganis and Timothy M. Alcorn -- ch. 8.; title: Marketing and compliance with HIPAA-- Princewell Imo and Thomas E. Colonna-- Index.